Technical Analysis for SCLX - Scilex Holding Company
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 5.98% | |
| NR7 | Range Contraction | 5.98% | |
| NR7-2 | Range Contraction | 5.98% | |
| Narrow Range Bar | Range Contraction | 5.98% | |
| Inside Day | Range Contraction | 5.98% | |
| Wide Bands | Range Expansion | 5.98% | |
| Gapped Up | Strength | 5.98% |
| Alert | Time |
|---|---|
| Up 10% | about 6 hours ago |
| Up 5% | about 9 hours ago |
| 10 DMA Support | about 10 hours ago |
| 60 Minute Opening Range Breakout | about 10 hours ago |
| Rose Above Previous Day's High | about 10 hours ago |
Get a Trading Sidekick!
- Earnings date: Unknown
Scilex Holding Company Description
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Organ Systems Pain Pharmaceutical Products Opioids Chronic Pain Pain Management Acute Pain Acute And Chronic Pain Palliative Care Nociception
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.3699 |
| 52 Week Low | 0.8002 |
| Average Volume | 1,106,049 |
| 200-Day Moving Average | 1.95 |
| 50-Day Moving Average | 1.31 |
| 20-Day Moving Average | 1.00 |
| 10-Day Moving Average | 0.87 |
| Average True Range | 0.10 |
| RSI (14) | 36.71 |
| ADX | 35.38 |
| +DI | 14.49 |
| -DI | 27.05 |
| Chandelier Exit (Long, 3 ATRs) | 1.25 |
| Chandelier Exit (Short, 3 ATRs) | 1.11 |
| Upper Bollinger Bands | 1.36 |
| Lower Bollinger Band | 0.64 |
| Percent B (%b) | 0.38 |
| BandWidth | 71.65 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.15 |
| MACD Histogram | 0.0095 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.05 | ||||
| Resistance 3 (R3) | 1.05 | 1.00 | 1.03 | ||
| Resistance 2 (R2) | 1.00 | 0.97 | 1.00 | 1.02 | |
| Resistance 1 (R1) | 0.96 | 0.95 | 0.98 | 0.96 | 1.01 |
| Pivot Point | 0.91 | 0.91 | 0.93 | 0.92 | 0.91 |
| Support 1 (S1) | 0.87 | 0.88 | 0.89 | 0.87 | 0.82 |
| Support 2 (S2) | 0.83 | 0.86 | 0.83 | 0.81 | |
| Support 3 (S3) | 0.78 | 0.83 | 0.81 | ||
| Support 4 (S4) | 0.78 |
